Cart 0 Product Products (empty)
No products
To be determined Shipping
0,00 € Total
Prices are tax excluded
Product successfully added to your shopping cart
Quantity
Total
There are 0 items in your cart. There is 1 item in your cart.
Total products (tax excl.)
Total shipping (tax excl.) To be determined
Total (tax excl.)
Data sheet of MAPK14 polyclonal antibody
| Brand | Abnova |
| Product type | Primary antibodies |
| Reactivity | Human,Mouse,Rat |
| Host species | Rabbit |
| Applications | IP,IHC,WB-Ce |
More info about MAPK14 polyclonal antibody
| Brand: | Abnova |
| Reference: | PAB8882 |
| Product name: | MAPK14 polyclonal antibody |
| Product description: | Rabbit polyclonal antibody raised against synthetic peptide of MAPK14. |
| Gene id: | 1432 |
| Gene name: | MAPK14 |
| Gene alias: | CSBP1|CSBP2|CSPB1|EXIP|Mxi2|PRKM14|PRKM15|RK|SAPK2A|p38|p38ALPHA |
| Gene description: | mitogen-activated protein kinase 14 |
| Immunogen: | A synthetic peptide corresponding to N-terminus of human MAPK14. |
| Form: | Liquid |
| Recommend dilutions: | Western Blot (0.5-4 ug/mL) Immunoprecipitation (10-20 ug/mL) Immunohistochemistry (10-20 ug/mL) The optimal working dilution should be determined by the end user. |
| Storage buffer: | In PBS (30% glycerol, 0.5% BSA, 0.01% thimerosal) |
| Storage instruction: | Store at -20°C. For long term storage store at -80°C. Aliquot to avoid repeated freezing and thawing. |
| Quality control testing: | Antibody Reactive Against Synthetic Peptide. |
| Note: | This product contains thimerosal: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only. |
| Product type: | Primary antibodies |
| Host species: | Rabbit |
| Antigen species / target species: | Human |
| Reactivity: | Human,Mouse,Rat |
| Application image: |  |
| Application image note: | Western blot analysis of MAPK14 expression in Jurkat cell lysate. |
| Applications: | IP,IHC,WB-Ce |
| Shipping condition: | Dry Ice |
| Publications: | Anti-septic effects of pelargonidin on HMGB1-induced responses in vitro and in vivo.Min G, Ku SK, Park MS, Park TJ, Lee HS, Bae JS. Arch Pharm Res. 2016 Dec;39(12):1726-1738. doi: 10.1007/s12272-016-0834-5. Epub 2016 Oct 24. |